Lack of Informed Consent for Psychotropic Medication
Penalty
Summary
Surveyors found that the facility failed to ensure a resident and/or representative was informed in advance about a prescribed medication and understood the reasons, risks, and benefits. Record review showed that the resident had a physician’s order dated 10/28/25 for clonazepam 0.5 mg once daily for insomnia. Further review of the medical record revealed there was no documented consent for the clonazepam. During an interview on 11/21/25 at 10:19 AM, the DON confirmed that there was no consent for the resident’s clonazepam and stated that consents should be completed for psychotropic active medications. This deficiency was identified for 1 of 5 residents reviewed for unnecessary medications, indicating that the required process of obtaining and documenting informed consent for a psychotropic medication was not followed for this resident.
